−3.0 TWD
−51.59 M TWD
125.27 M TWD
About PURIBLOOD MEDICAL CO LTD
Sector
Industry
CEO
Yan Wen Chen
Website
Headquarters
Hsinchu
Founded
2016
ISIN
TW0006847007
FIGI
BBG0137PMXY5
Puriblood Medical Co., Ltd. engages in the developing of technology for blood cell separation that is supported by a research center R&D center for membrane technology RDCMT. PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic bias Surface Coating Technology ZISC technology The company was founded by Dr. Yung Chang in 2016 and is headquartered in Hsinchu, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6847 is 103.0 TWD — it has increased by 0.50% in the past 24 hours. Watch PURIBLOOD MEDICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange PURIBLOOD MEDICAL CO LTD stocks are traded under the ticker 6847.
6847 stock has fallen by −2.87% compared to the previous week, the month change is a 10.57% rise, over the last year PURIBLOOD MEDICAL CO LTD has showed a −5.94% decrease.
6847 reached its all-time high on Dec 10, 2021 with the price of 190.0 TWD, and its all-time low was 82.5 TWD and was reached on Nov 8, 2024. View more price dynamics on 6847 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6847 stock is 3.47% volatile and has beta coefficient of −0.11. Track PURIBLOOD MEDICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is PURIBLOOD MEDICAL CO LTD there?
Yes, you can track PURIBLOOD MEDICAL CO LTD financials in yearly and quarterly reports right on TradingView.
6847 net income for the last half-year is −12.42 M TWD, while the previous report showed −33.33 M TWD of net income which accounts for 62.74% change. Track more PURIBLOOD MEDICAL CO LTD financial stats to get the full picture.
No, 6847 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PURIBLOOD MEDICAL CO LTD EBITDA is −34.63 M TWD, and current EBITDA margin is −33.77%. See more stats in PURIBLOOD MEDICAL CO LTD financial statements.
Like other stocks, 6847 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURIBLOOD MEDICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURIBLOOD MEDICAL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURIBLOOD MEDICAL CO LTD stock shows the sell signal. See more of PURIBLOOD MEDICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.